Subgingival controlled release of antimicrobial agents in the treatment of periodontal disease
Related Experiment Video
Updated: Oct 29, 2026

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
1Atrix Laboratories, Inc., Fort Collins, CO 80525, USA.
Abstract:
Local drug delivery of antimicrobics by sustained release delivery systems can be used to treat periodontal disease. Advantages of these systems may include biodegradation of the system, maintaining high levels of antibiotic in the gingival crevicular fluid (GCF) for a sustained period of time and ease of use with high patient acceptance. This review will identify human in vivo clinical and microbiological studies. Sustained release formulations, application methods, clinical results and microbiological effects are discussed.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Stimuli-Activated
Oral Drug Delivery Systems: Continuous-Release Systems
Gene Regulation in Microbial Communities: Quorum Sensing
Oral Drug Delivery Systems: Delayed-Release Systems
Biological Methods for Microbial Control